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ABSTRACT
CANCER RISK PREDICTION WITH NEXT GENERATION SEQUENCING
DATA USING MACHINE LEARNING
by
Nihir Patel
The use of computational biology for next generation sequencing (NGS) analysis is
rapidly increasing in genomics research. However, the effectiveness of NGS data to
predict disease abundance is yet unclear. This research investigates the problem in the
whole exome NGS data of the chronic lymphocytic leukemia (CLL) available at dbGaP.
Initially, raw reads from samples are aligned to the human reference genome using
burrows wheeler aligner. From the samples, structural variants, namely, Single
Nucleotide Polymorphism (SNP) and Insertion Deletion (INDEL) are identified and are
filtered using SAMtools as well as with Genome Analyzer Tool Kit (GATK).
Subsequently, the variants are encoded and feature selection is performed with the
Pearson correlation coefficient (PCC) and the chi-square 2-df statistical test. Finally,
90:10 cross validation is performed by applying the support vector machine algorithm on
sets of top selected features. It is found that the variants detected with SAMtools and
GATK achieve similar prediction accuracies. It is also noted that the features that are
ranked with the PCC yield better accuracy than the chi-square test. In all of the analyses,
the SNPs are identified to have superior accuracy as compared to the INDELs or the full
dataset. Later, an exome capture kit is introduced for analysis. The SNPs, ranked with the
PCC, along with the exome capture kit yield prediction accuracy of 85.1% and area under
curve of 0.94. Overall, this study shows the effective application of the machine learning
methods and the strength of the NGS data for the CLL risk prediction.
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CHAPTER 1
INTRODUCTION

1.1 Objective
Advances in genomic sequencing techniques have opened a wide range of opportunity to
observe genetic variations and diseases more closely. Nevertheless, the massive Next
Generation Sequencing (NGS) data demanding an intense computing makes it a
challenging task to extract meaningful information that can be correlated with the fatal
diseases such as the cancer. Many researchers have adapted the supervised machinelearning methods to analyze such enormous data. Since such methods take the advantage
of relationally structured biological data and utilize only partial information from the data
to learn a model. Ultimately, the model can either be applied to the complete dataset or to
any relevant independent dataset to classify sensible biological information.
This thesis seeks to investigate a multiple aspects associated with the cancer
genomics and the cancer risk predictions with the aid of the supervised machine learning
method. The primary purpose of the analysis is to develop a strategy that can effectively
classify chronic lymphocytic leukemia (CLL) subjects into tumor and non-tumor, by
applying machine-learning algorithm on the key structural variants. The variants were
extracted from the whole exome sequencing (WES) data of the CLL. The study, first,
compared the performance of two popular variant calling tools, namely, (1) SAMtools (Li
et al., 2009) and (2) Genome Analyzer Tool Kit (McKenna et al., 2010). Afterwards, a
novel, genotypes based variant encoding method was introduced and the effectiveness of
the method was compared with the previous encoding method used in genome wide
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association studies (GWAS) (Roshan et al., 2011). In subsequent step, an investigation
was carried out to evaluate the performance of two statistical variant ranking strategies,
namely, (1) Pearson correlation coefficient (PCC) and (2) chi-square test. In the final
phase of the analysis, an exome kit was introduced for variant detection, and the
improvement in the classification accuracy was assessed and is presented.

1.2 Background
The Chronic Lymphocytic Leukemia (CLL) is a cancer of white blood cells. According
to the Cancer Facts and Figures 2014 (distributed by American Cancer Society), in USA
itself, 4600 deaths associated with CLL were reported, and about 15720 new cases of
CLL are expected for the year. Existing methods can only identify the CLL after its
occurrence, but in many cases it is too late before the disease can be diagnosed.
Previously, for Crohn’s disease and ulcerative colitis diseases, the predictions with an
Area Under Curve (AUC) of 0.86 and an AUC of 0.82 were reported, respectively (Wei
et al., 2013). Likewise, an AUC of 0.82 for type-2 diabetes, and an AUC of 0.83 for
bipolar disease, using bootstrap method has been previously conveyed (Burton et al.,
2010). But yet to date, there is no known effective pre-diagnostic method have been
implemented, that can predict the CLL or any other cancers. Traditional methods, such
as, microarray expression analysis and Genome Wide Association Studies (GWAS) were
unable to produce prediction accuracy significant enough to utilize it for clinical
purposes. And hence, it is important to initiate a study for a better risk prediction of the
CLL that incorporates a distinct approach. Since, the CLL disease is associated with the
genetic mutations, the genetic data obtained from the Next Generation Sequencing (NGS)
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techniques, may lead to an efficient diagnostics scheme. In recent years, use of the
computational science to extract important biological information from the NGS data has
been increased, dramatically. This is due to the fact that, the computational methods
provide a cost efficient reproducibility of an investigation, which can serve as an
alternative to the expensive wet lab experiments. The study seeks to take an advantage of
such computational approach to assessed risk prediction accuracy in the CLL by using
the WES data, targeted to cover the human exome regions.
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CHAPTER 2
METHODS

This study involves a substantial analysis of the WES data, which includes a large
number of transitional steps, producing a various types of files by utilizing several
publically available tools. Hence, in the following sections, the details of the intermediate
files and tools involved in the analysis will thoroughly be discussed, simultaneously, with
experimental procedure.

2.1 Datasets
For the analysis, raw short reads sequence data were obtained from the database of
Genotypes and Phenotypes (dbGaP) from the study phs000435.v2.p1 (Wang et al., 2011).
All the samples were produced to achieve a mean coverage of 140X of human exome
regions. It contained 76 Base Pair (bp) long, pair ended, exome data generated using
Illumina Genome Analyzer-II and Illumina hiseq 2000. The dataset contains, 355
samples, which includes 186 tumor samples, and 169 non-tumor samples produced from
the matched germ line non-cancerous cells of 169 tumor patients (the 169 sample from
186 tumor) (Wang et al., 2011). For this analysis, 153 tumor samples and 144 non-tumor
samples were considered. The rest of the samples were excluded from the analysis due to
one of three reasons, which includes (1) excessive size (greater than 20 gigabytes) (2)
missing data (3) erroneous samples. Additional required material beside the sample data,
such as the human exome region coordinates (the exome kit) and publically available
standard variant datasets were obtained from GATK bundle (2.8 b37) available through
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ftp://gsapubftp-anonymous@ftp.broadinstitute.org/bundle (McKenna et al., 2010). The
Table 2.1 shows all the files with brief information of content and their roles in Variant
Score Quality Recalibration (VSQR). VSQR process is a GATK protocol used in the
analysis to filter variants (See Section 2.3). Beside that, the human reference genome
(version GRCh37.p13) for mapping reads was obtained from the Genome Reference
Consortium accessible at http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/.

Table 2.1 Resources Used in GATK for Variant Filtration
Resource Used
Exome intervals
dbSNP variants
HapMap
OMNI 2.5
Genotypes
1000 Genome
Phase-I SNPs
Mills_and_1000G
_gold_standards

Description

Role in VSQR process

Contains putative exome
region coordinates
SNPs found in dbSNP
databases
HapMap genotypes and VCFs
sites for SNPs
OMNI 2.5 genotypes for 1000
Genomes samples and SNPs
VCF sites
1000 Genomes Phase I SNPs
calls
INDELs calls validated with
high degree of confidence

N/A
Contains Known sites and not used
as training resource
Contains True sites and used as
training resource to filter SNPs
Contains True sites and used as
training resource to filter SNPs
Contains Non-True sites and used
as training resource to filter SNPs
Known and True sites and used as
training resource to filter INDELs

Source: (Auwera et al., 2013, DePristo et al., 2011 and McKenna et al., 2010)

2.2 Data Pre-Processing
Figure 2.1 represents, the experimental steps followed to obtain variants from the raw
reads. For the major pre-processing, SAMtools (version 0.1.18) was considered.
SAMtools comprised of multiple utilities, to perform sorting, merging, indexing and
filtering of the sequencing data (Li et al., 2009). The samples were received as Sequence
Archive Read (SRA) format files. The SRA files were converted to the fastq format using
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the fastq-dump utility of SRAtoolkit provided by the National Institute of Health (NIH)
and is accessible at http://eutils.ncbi.nih.gov/Traces/sra/?view=software. The fastq format
comprise of the reads containing nucleotides and the quality scores associated with the
reads. Subsequently, the reads were mapped against the human reference genome using
BWA-MEM (version 0.7a-r405) by applying all default parameters (Li & Durbin, 2009).
BWA is a popular mapping tool that implements the Burrows-Wheeler transform
algorithm. BWA was chosen as it can align the sample reads to the massive human
reference genome quickly and efficiently (Fonseca et al., 2012 and Hatem et al., 2013).
As shown in Figure 2.1, the BWA constructs output files in the Sequence Alignment/Map
(SAM) format. Using SAMtools, the SAM files were converted to Binary SAM (BAM)
files and then the files were indexed and sorted. Such BAM files are consist of reads
alignments between sample sequence and reference sequence. Indexing and sorting
procedures, allows a quick access of the massive alignment data within BAM files. An
AddOrReplaceReadGroups utility of PICARD tool (Version 1.8), accessible at
http://broadinstitute.github.io/picard/, was then used to add read group information to the
BAM files.

Afterwards, using SAMtools, the unmapped reads and the reads with

mapping quality score (MAPQ) below 15 were eliminated. The resulting filtered BAM
files were then sorted and indexed. Thereafter, the duplicate reads were removed from the
filtered BAM files using the MarkDuplicates utility of PICARD tool. Both of the above
steps are important, as they remove the low quality reads and the duplicate reads that
largely contributes to the false positive variants.
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Figure 2.1 Flow chart showing experimental steps.

2.3 Variant Calling and Filtering
The variants were detected jointly, using consensus calling for 297 samples with
SAMtools as well as with GATK. Initially, the raw variants were generated using
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SAMtools together with BCFtools. The process yielded a Variant Calling Format (VCF)
file containing raw variants. The VCF file includes two types of structural variants,
namely, Single Nucleotide Polymorphism (SNP) and Insertion Deletion (INDEL). The
specifications for the VCF format are provided at http://samtools.github.io/htsspecs/VCFv4.1.pdf. Likewise, a raw VCF file was also generated using GATK, following
the best practice guidelines provided by the Broad Institute (Auwera et al., 2013). Even
though SAMtools and GATK serve a common purpose of calling variants, they both
follow distinct steps when it comes to filtering variants. For the variants obtained with
SAMtools, filtering was simply done by applying all the default parameters of “vcfutil.pl
varFilter” utility provided under the SAMtools. On the other hand, to filter the variant
attained with GATK, the Variant Score Quality Recalibration (VSQR) protocol was
executed. The VSQR procedure involves two steps, (1) variant recalibration step and (2)
apply recalibration step. Briefly, the first step generates a Gaussian mixture model using
true sites from the datasets discussed in the Table 2.1 and outputs a recalibration file
(DePristo et al., 2010). In the second step, the model created in the previous step is
applied to the variants in VCF files and the variants are collected into a new VCF file,
with a VQSLOD scores added to them. For a given variant, the VQSLOD score is the log
odd ratio for the variant to be true versus it to be false (DePristo et al., 2010).
Subsequently, a filtering threshold, namely, ‘tranche sensitivity’ is applied to the variants
(DePristo et al., 2010). If the tranche sensitivity threshold is X%, then GATK considers,
the VQSLOD score of X% of the variants from training set and calculates the VQSLOD
threshold. If a given variant has the VQSLOD score above the threshold, it is considered
a true variant and flagged as PASS in QUAL field (in VCF files). In contrast each variant
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with VQSLOD score below the threshold is treated as false positive (DePristo et al.,
2010). Using the VQSLQD threshold, the low quality variants were flagged, and then
they were removed using SelectVariants utility of GATK. The high quality variants were
collected in to yet another VCF file and the file was used in succeeding analyses. Herein,
tranche sensitivity threshold was kept 99.9% for SNPs and 99.0% for INDELs.

2.4 Variant Encoding and Depth Filtering
Since the input matrix of the supervised machine learning methods (see Section 2.5) must
be in the form of feature vectors, each variant was encoded into an integer using
corresponding genotypes from the VCF files and a feature vector was generated for each
individual sample. In the VCF files, the genotypes are assigned as X/Y format. If X (or
Y) is reference allele, then it is always represented using 0. The other representations of
X and Y varies and the representing number can go as high as the maximum number of
the alternative alleles allowed by the variant detector tool. For SAMtools/BCFtools
default number of maximum alternative alleles is 2 and for GATK the number is 6.
Variant encoding was done using two different methods. Let the first encoding
method be P and the second method be Q. For the method P, the zygosity of the genotype
was considered, where a variant was represented as 0 if it is a homozygous reference
allele (i.e. 0/0), 1 if it is a heterozygous allele (i.e. 0/1, 0/2, etc.), and 2 if it is a
homozygous alternate allele (i.e. 1/1, 2/2, 3/3 etc.). For the method Q, the variants were
simply encoded using 7(X) + Y. The encoding was done such that each genotype is
mapped to a distinct integer. Using both the methods, the variants were encoded into a
data matrix. A fraction of the resulting data matrix is shown in Figure 2.4, where the
sample’s IDs are shown in the first column and the feature (variant) names are indicated
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in the first row. The feature names are represented with three parameters (1) variant type
where ‘S’ represents SNPs and ‘I’ represents INDELs (2) chromosome number and
(3) position of variant in the chromosome. The rows of the matrix correspond to feature
vectors and the numbers in the data matrix resembles the encoded genotype.
While encoding the variants, the read depth (DP in INFO field) filtering was
executed, and the variants holding DP score above 300 and below two were filtered out.
These variants come from the distribution that has an average coverage of 140X. Thus, it
is very implausible to have a true variants containing DP above twice the size of the
coverage (i.e. 300). Alternatively, a variant with the DP score below two is very unlikely
to be a true variant because it does not have enough supporting reads. Both of these types
of variants have quite high chances of being false positive and hence it is valid to exclude
the variants from the analyses.

Figure 2.2 Encoded data matrix showing distribution of samples and features.
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2.5 Supervised Machine Learning and Feature Selection
Following the variant identification and the encoding procedure, a supervised machine
learning analysis was performed. Supervised machine learning is a popular approach that
utilizes labeled (classified) data to learn a model, and predicts the labels of unclassified
data by applying the model. In the supervised method, the sample rows of a data matrix
represents feature vectors in a space dimensions given by features from the columns (See
Figure 2.4). Here, in the analysis, the data were separated into train and validation sets, so
that the supervised model can be learned using the train data and the predictions can be
made on the validation data using the model.
Cohort analysis, such as the one performed here yields a very large number of
features (variants), which reduces the classifier’s ability to separate data. Hence, it is
required to extract few significant features that aid to classify data more efficiently. Thus
top-K features were selected by arranging them in the decreasing order of the absolute
values of the Pearson correlation coefficient (PCC) (Guyon et al., 2003). The K was
incremented by 10, up to 100 features, and from there it was incremented by 100, for
maximum of 1000 features. For jth variant, PCCj can be represented as equation 2.1,
where the Xi,j is the encoded value of the genotype for the ith sample and the jth variant,
and the Yi is the label for the ith sample. The tumor (case) and non-tumor (control)
samples were labeled as -1 and 1, respectively.

!
!

!""! = !
!
!

(2.1)

!!,! − !!! !!! − ! !
!

!!,! − ! !!! ! ×
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!
!

!

!!, − !! ! !

For comparison purposes, in some analyses, a chi-square df-2 test was considered
for the feature selection procedure. For the chi-square test, top-K feature sets were
extracted by arranging variants in the decreasing order of chi-square P-values.

2.6 Cross-Validation and Accuracy Assessment
For cross-validation, the binary classification approach was considered. At first, the data
matrix (discussed in Section 2.4) was randomly separated by rows (subjects), into 90 %
training and 10% validation set. Secondly, the feature selection was performed onto
training set and the top features were extracted as explained in the Section 2.5. For each
feature set, a supervised learning model was created using the support vector machine
(SVM) algorithm (Cortes et al., 1995), implemented in the SVM-light program
(Joachims, 1999). The model created in training phase was applied to the validation set
and the predictions were made. All the above steps were repeated for the multiple random
splits and the average classification accuracy was assessed using 1- balanced error rate
(BER) (Guyon et al., 2004). As shown in equation 2.2 the BER is an average of the error
rate of the controls and the error rate of the cases. Herein, the error rate is calculated by
dividing misclassified labels with true labels.

1
!"#$%&##"'"()!!"#$!%!"#$%"&
!"#$%&##"'"()!!"#$!%!"#$#
!"# = ×
+!
!
2
!"#$!!"#$!%!"#$%"&
!"#$!!"#$!%!"#$#
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(2.2)

CHAPTER 3
RESULTS AND DISCUSSION

Throughout the study, multiple methods (or tools) were used to perform identical
analysis. In the succeeding sections, the experimental outputs and the performance of
each method (or tool) will be addressed.

3.1 Extracting Analysis Ready Sample
During the data pre-processing, 23 samples were removed from the analysis as discussed
in the Section 2.1, which left 332 samples for the remaining analyses. Initially, the
variants were detected with SAMtools using the 332 samples, without using any exome
kit. Subsequently, the variants were filtered and encoded into the data matrix. The
resulting data matrix found to have only 6000 variants. Without the filtering step, the data
matrix would have had 22 million variants. Thus, considering this suspiciously low
number of variants, the data matrix was re-analyzed, which revealed that all the 6000
identified variants are resided only in the first chromosome, and the rest of the variants
were removed, since, they were absented (or have low coverage) in at least one sample.
Meaning if a variant is missing (or have low coverage), even in one sample out of 332,
then the variant will be removed. Presence of all variants in single chromosome, suggests
that, it is a sequencing artifacts, which likely occurs due to systematic bias in sequencing.
Therefore to avoid the bias, samples missing an excessive number of variants were
identified. To do that, at first, the variants present in a large number of samples were
extracted, followed by the identification of the samples, missing the large number of
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variants. More precisely, high occurring variants that present in at least 330 samples
(90% of samples) were extracted. After that, the samples, missing more than 10% of the
variants were identified. The procedure identified 35 more samples that need to be
removed from the investigation. In the later steps, the same procedure was repeated with
GATK while including the exome kit in the analysis. The method identified the same 35
samples for both SAMtools and GATK, and hence mutually validating the sample
removal procedure.

3.2 SAMtools vs. GATK
After removing the samples, all the steps discussed in the Sections 2.3 to 2.6 were
repeated using both SAMtools and GATK, without providing an exome kit and by
applying the method P for encoding (Section 2.5). Figure 3.2 compares an average
cross-validation accuracy of 10 random splits between SAMtools and GATK. Herein, the
feature selection (Section 2.5) was performed using the PCC and the SNPs were encoded
using the method P. As it can be seen from in the Figure 3.1, almost in all cases, GATK
performed better. Even though GATK clearly yielded a better prediction accuracy, the
comparison between SAMtools and GATK in not quite rational as both uses distinct
types of variant filtering strategy. Nonetheless, the comparison can provides a basic idea
of how well two popular variant detecting tools perform. The further analyses were
performed using only GATK because (1) SAMtools tends to assign random genotypes
values to the variants when they have zero DP value. Ideally, such variants indicate
missing information and should be avoided from the analysis. On the other hand, GATK
efficiently identifies such variants and assigns (‘./.’) to their genotypes. (2) The VSQR
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procedure of GATK utilize high confidence known variants calls and provides a single
VQSLOD score for filtering, whereas with SAMtools user have to define multiple
filtering parameters, and tuning such parameters is a challenging task for such a massive
study. (3) SAMtools lacks the variant annotation function provided by GATK.

Prediction Accuracy SAMtools vs GATK
1
0.9
0.8

Accuracy

0.7
0.6
0.5
0.4
0.3

SAMtools

0.2

GATK

0.1
0
Top10

Top20

Top30

Top40

Top50
Top60
Top Ranked SNPs

Top70

Top80

Top90

Top100

Figure 3.1 Average cross-validation accuracy comparison of SAMtools and GATK over
10 random 90:10 training validation splits. The SNPs were ranked with the PCC and
were encoded with the method P. The Error bars represents standard deviations.

3.3 Comparison of Feature Selection Methods
As discussed in the Section 3.2, the remaining experiments were carried out with GATK.
At first, the effect of two different types of feature ranking methods (1) PCC and (2) chisquare was analyzed by comparing the classification accuracy on all features (SNPs +
INDELs) with 100 random splits. Exome kit was excluded for this procedure, which
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yielded 296860 features, which were then encoded with the method P (encoding with 0, 1
and 2). Here, only the method P was considered, because it was not plausible to apply
chi-square df-2 test to the variants encoded with the method Q. The method Q produces
the data matrix with integers ranging from 0 to 48, and that too with the columns (of the
encoded matrix) containing varying sets of integers. Thus, in the situation, if one wants to
apply the chi-square test, then for each column, an appropriate degree of freedom must be
calculate separately, which is a quite complicated task especially, for a large data matrix
such as the one used here.
For statistical consistency, the labels for each of 100 splits were kept same,
meaning for an individual experiment, train set and validation set were identical for both
the PCC and the chi-square ranking. Figure 3.2 shows a comparison of these two ranking
methods. For the PCC ranking, top-30 variants yielded the highest accuracy of 66.4%,
and for the chi-square ranking, top-20 variants achieved the highest accuracy of 65.1%.
As it can be seen from Figure 3.2, there is a negligible difference in the classification
accuracy between two methods for first 100 variants, but as the number of variants
increases, the PCC constitutively performs better then the chi-square. Therefore, based on
the preliminary analysis, only the PCC was used for the feature selection purposes in the
remainder of the studies.
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Figure 3.2 Average cross-validation accuracy comparison of top PCC and chi-square
ranked features on 100 random 90:10 training validation splits with GATK. The variants
were encoded using the method P and the error bars represents standard deviations.

3.4 Comparison of Encoding Methods
Here, in this section, the performances of two different encoding methods, discussed in
Section 2.4, are compared. It was not feasible to encode all the variants using the
method P and thus, the method Q had a higher number of variants. The variants missed in
the method P, are the variants that contains genotypes such as 1/2, 2/3, 3/4 etc. In
practice, zygosity of such genotypes cannot be correctly inferred into three categories
discussed in Section 2.4, and that is why, such variants were excluded from the analysis.
On the other hand, the method Q (encoding using 7X + Y) is designed to include all
variants. In fact the sole purpose of introducing a novel encoding method (the method Q)
was to avoid the loss of high quality variants that were already passed through the
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rigorous filtering. As expected, inclusion of all variant did make difference in the
classification accuracy. As it can be seen in Figure 3.3, when the classification accuracy
was compared, the method Q performed better than the method P, with SNPs alone and
also with all variants but with the INDELs, the method P yielded higher accuracy.
However for the INDELs, the classification accuracy with both the methods was close to
the random guess and hence the performance of the methods was not evaluated based on
results obtained with the INDELs. For further studies, the Method Q was considered,
because overall it performed better then the method P. Table 3.1 shows the number of
encoded genotypes with each method and the highest accuracies associated with it.

Method P

Method Q

Figure 3.3 Average cross-validation accuracy with top PCC ranked features using the
encoding method P and Q, on 100 90:10 training validation splits. Error bars represents
standard deviations.

Table 3.1 Numbers of Variants and Obtained Highest Accuracies
Variant
Type
All Features
SNPs
INDELs

Method P
Number of
Variants
296860
284468
12153

Method Q

Highest Accuracy
66.4 % (Top-30)
67.9 % (Top-30)
53.6 % (Top-10)
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Number of
Variants
297924
284591
13333

Highest Accuracy
68.3 % (Top-20)
69.9 % (Top-20)
47.6 % (Top-10)

3.5 Effect of Capture Kit
Previously, all of analyses were done without any exome kit. The exome kit restricts
variant identifications to the only genomic regions that can be encoded into genes. The
primary reason to exclude the exome kit from the analysis was to include all putative
variants placed near the exonic regions, which otherwise, would not have been taken into
consideration. But the filtering recommendation provided by GATK were specifically
designed for exome specific regions and it was not clear how effective they will be, if the
exome kit is excluded from the analysis. Also, previously, no known study found that can
provide guidance for proper filtering parameters, and it was beyond the scope of this
investigation to tune all the parameters and then to choose the best one. Hence, it was
decided to repeat previous experiments including an exome kit. For the analysis with the
exome kit, the variants were identified using GATK and the encoding was done using the
method Q (Section 2.4). For the features selection, the PCC was considered. Figure 3.4
compares an average classification accuracy of with and without the use of an exome kit.
Unexpectedly, inclusions of the exome kit yielded a quite higher classification accuracy
of 85.1%, as compare to 69.9% obtained without the exome kit. With exome kit, 122392
SNPs and 2200 INDELs were identified. As it can be seen in Figure 3.4 that the exome
kit analysis achieved significantly higher accuracy with all three forms of datasets. In
successive steps, area under curve (AUC) value was calculated for various numbers of
top-ranked variants. The AUC values obtained with and without the exome kit were
compared, and are reported in Figure 3.5. The AUC values were only calculated for the
SNPs because the SNPs gave the highest classification accuracy, regardless the use of an
exome kit. The highest AUC observed was 0.94 (Top70 SNPs) with the exome kit and
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0.75 (Top40 SNPs) without the exome kit. To further verify the consistency of the
results, the classification accuracy for the encoding method P was also assessed, the
results are shown in Figure 3.6. Even with the encoding method P, the exome kit yielded
quite higher accuracy of 84.7% (Top90) as compare to 67.9% (Top-30) obtained without
the exome kit. With the exome kit, just as the previous results (Figure 3.3), the method Q
achieved a slightly higher accuracy (85.1%) than the method P (84.7%). One more
experiment was performed, where data were split into 50:50 training validation sets,
instead of splitting into 90:10. For the data, feature selection was performed using the
PCC method and the encoding was done using the method Q. The average classification
accuracy with the SNPs alone, with the INDELs alone and the full dataset, are shown in
Figure 3.7. The highest accuracy of 82.2% was observed with the SNPs alone as well as
with the full dataset. As it can be seen in Figure 3.7 (left), the accuracy curves for the
SNPs and the full dataset almost exactly overlaps, which suggests that INDELs have
negligible effect on the classification.

With exome kit

Without exome kit

Figure 3.4 Average cross-validation accuracy comparison between with and without the
exome kit on 100 90:10 training validation splits. The variants were ranked using PCC
and were encoded using the method Q. The error bars represents standard deviations.
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Figure 3.5 Area under curve values for the Q encoding and top PCC ranked SNPs,
obtained with and without the exome kit. Error bars represents standard deviations.

Figure 3.6 Average cross-validation accuracy for the encoding P and top PCC ranked
SNPs obtained with and without the exome kit on 100 90:10 training validation splits.
The error bars represents standard deviations.
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Figure 3.7 Average cross-validation accuracy with top PCC ranked features with exome
kit on 100 50:50 training validation splits. Encoding was done using method Q and the
error bars represents standard deviations.

3.6 Principle Component Analysis
Two-dimensional plots of top-80 (left) and top-30 (right) SNPs are shown in Figure 3.8.
The plots were obtained with principle component analysis (PCA) (Alpaydin, 2004),
where X-axis represents first principle component and Y-axis represents second principle
component. PCA is used to project the high dimensional data to the lower dimensions so
that the data separation can visually be observed. As it can be seen in Figure 3.8, in both
experiments, the data are not clearly separated, which suggests that the data are
challenging, and hence, supporting the choice to use supervised leaning approach for the
data classification. Even though, the data are not quite separated, the data obtained with
the exome kit shows a better separation as compare to the data obtained without the
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exome kit (Figure 3.8).

With Exome Kit (Top-80)

Without Exome Kit (Top-30)

Figure 3.8 PCA plots for top-80 SNPs obtained with exome kit and top-30 SNPs
obtained without exome kit.
3.7 Predictive SNPs
With the exome kit, top-80 SNPs, and without the exome kit, top-30 SNPs yielded the
highest average classification accuracy over 100 random splits. An intersection of top-80
SNPs (with the exome kit) across the 100 sets yielded 48 common SNPs. Likewise, An
intersection of top-30 SNPs (without the exome kit) across the 100 sets yielded nine
common SNPs. The SNPs were tagged as predictive SNPs. The 48 predictive SNPs
obtained with the exome kit, achieved an average AUC of 0.93 with standard deviation of
0.04, whereas the nine predictive SNPs obtained without the exome kit, yielded an
average AUC of 0.72 with standard deviation of 0.09. Additional information regarding
these predictive SNPs was obtained using a tool called wANNOVAR (Chang & Wang,
2012). Table 3.1 and Table 3.2 provides the additional details regarding the predictive
SNPs identified with the exome kit, in only chromosome 14, and Table 3.2, shows the
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same for the rest of the chromosomes. Similarly, Table 3.3 shows the additional
information about the nine predictive SNPs identified without the exome kit. As it can be
seen from the Table 3.1 and 3.2, that many predictive SNPs were found in exonic regions
with few exceptions. Hypothetically, if the exome intervals are used to call variants, then
all the variants should only be in the exonic regions but this was not observed here. The
phenomenon can be explained by the fact, that the exome kit are designed to cover some
extra areas on the both end of putative exonic regions, this is done purposely to include
flanking regions in the end of the associated gene. It is likely that the non-exonic
predictive SNPs belong to the flanking regions. If the exome kit is not provided, then the
SNPs can be found in any regions, and that explains why there are many SNPs in the
non-exonic regions in Table 3.3 but not in Table 3.1 or Table 3.2. In all three tables the
last two columns were added manually along with the information obtained with
wANNOVAR. From the two columns, the first column contains number of case subjects
containing the particular mutation and the second column represents the same for the
control subjects. Theoretically, a cancer leads to the genetic alterations, which suggests
that the mutations shown in Table 3.1–3.3, should have high occurrence in the case
subjects as compare to the control subjects. But, surprisingly, the higher mutation rate
was observed in control subjects. Previously, a study have identified that non-mutated
IGHV gene is associated with more aggressive form of the CLL (Ferrer et al., 2004).
Also, the gene was used to measure the CLL progression, based on the gene’s
non-mutated status (Rassenti et al., 2004). These studies suggest that non-mutated IGHV
(chromosome 14) may contribute to the CLL, and thus explaining the higher mutation
rate in control samples of the predictive SNPs.
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Table 3.2 Additional Information of Predictive SNPs in Chromosome 14 (With the
Exome kit)
Chr:Pos

Ref Alt

dbSNP ID

Region

Gene

Case Control

14:106494153
14:106494221
14:106733287
14:106733289
14:106733290
14:107034846
14:107034863
14:107034873
14:107034967
14:107113763
14:107113780
14:107113785
14:107113855
14:107113858
14:107113968
14:107179022
14:107282791
14:107282809
14:107282813
14:107282814
14:107282836
14:107282846
14:107282852
14:107282859
14:107282872
14:107282909
14:107282926
14:107282935
14:107282973
14:107282988

T
T
A
C
C
T
C
G
T
A
G
C
A
A
C
C
A
T
C
A
T
G
T
G
T
T
A
A
G
C

.
.
.
.
.
rs199610746
rs199809351
rs199524561
rs72686844
rs377318229
rs200164853
rs201264785
rs111637096
rs111853090
rs113324720
rs2157615
.
rs201928713
rs199801132
rs200749603
rs201902530
rs200859769
rs201336503
rs201095197
rs61741319
rs202202987
rs149038822
rs201762529
rs200848671
.

exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
downstream
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic
exonic

IGHV2-5
IGHV2-5
IGHV1-24
IGHV1-24
IGHV1-24
IGHV5-51
IGHV5-51
IGHV5-51
IGHV5-51
IGHV3-64
IGHV3-64
IGHV3-64
IGHV3-64
IGHV3-64
IGHV3-64
IGHV2-70
IGHV7-81
IGHV7-81
IGHV7-81
IGHV7-81
IGHV7-81
IGHV7-81
IGHV7-81
IGHV7-81
IGHV7-81
IGHV7-81
IGHV7-81
IGHV7-81
IGHV7-81
IGHV7-81

42
30
26
25
24
68
68
59
70
45
61
61
68
68
65
21
6
10
11
11
30
51
54
60
62
65
57
55
49
16

C
A
C
A
G
G
T
C
C
G
A
T
G
G
A
A/G/T
C
C
A
G
A
A
C
A
A
C
T
T
C
G

Source: (Chang & Wang, 2012)
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1
1
5
4
4
97
97
87
98
81
93
96
97
97
97
0
39
59
56
55
70
100
104
108
109
112
111
107
95
54

Table 3.3 Additional Information of Predictive SNPs in All Chromosomes except
Chromosome 14 (With the Exome kit)
Chr:Pos

Ref Alt

dbSNP ID

Region

Gene

Case Control

2:90139116
2:169780261
2:169780287
6:30553070
6:30553073
6:31749930
10:82034884
12:11286309

G
G
T
G
T
C
C
G

A
A
A
C
C
G
A
C

rs201820003
.
.
.
.
.
.
.

exonic
exonic
exonic
exonic
exonic
exonic
exonic
intergenic

86
0
0
0
0
0
0
8

136
29
13
15
16
26
11
29

15:22489958

C

T

rs111826301 intergenic

66

111

15:22489966

A

C

rs72687799

intergenic

68

111

15:22489988

G

A

rs72687801

intergenic

70

112

15:22490019

T

C

rs112521162 intergenic

69

113

16:70305806

G

A

.

intergenic

0

81

16:70305812

C

A/T

.

intergenic

0

82

18:43669558

T

C

.

exonic

0

12

19:1390897

C

T

.

intergenic

0

12

19:34884932

T

C

.

intergenic

IGKV1D-16
ABCB11
ABCB11
ABCF1
ABCF1
VARS
MAT1A
TAS2R19PRB1
RP11-2F9.1
TUBGCP5
RP11-2F9.1
TUBGCP5
RP11-2F9.1
TUBGCP5
RP11-2F9.1
TUBGCP5
EXOSC6
DDX19B
EXOSC6
DDX19B
ATP5A1
AC005330.1
PCSK4
CTD-2518G19.1
CTD-2588C8.1

0

18

Source: (Chang & Wang, 2012)
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Table 3.4 Additional Information of Predictive SNPs in All Chromosomes (Without the
Exome kit)
Variant

Ref Alt

14:107034967
14:107179022

T
C

15:22473106

dbSNP ID

Region

Gene

Case Control

C
rs72686844
A/G/T rs2157615

exonic
exonic

70
21

98
0

G

A

rs72687776

intergenic

78

117

15:22489900

T

C

rs113115466 intergenic

66

97

15:22489958

C

T

rs111826301 intergenic

66

111

15:22489966

A

C

rs72687799

intergenic

68

111

15:22489988

G

A

rs72687801

intergenic

70

112

15:22490019

T

C

rs112521162 intergenic

IGHV5-51
IGHV2-70
RP11-2F9.1
TUBGCP5
RP11-2F9.1
TUBGCP5
RP11-2F9.1
TUBGCP5
RP11-2F9.1
TUBGCP5
RP11-2F9.1
TUBGCP5
RP11-2F9.1
TUBGCP5

69

113

Source: (Chang & Wang, 2012)

3.8 Genes Associated with CLL
From various chromosomes, multiple genes associated with the predictive SNPs were
identified. Remarkably, 30 out of 48 predictive SNPs were found alone in the
chromosome 14 and almost all of them were associated with IGHV gene. Previously,
IGHV gene was identified to be associated with the CLL, which justify the high
occurrence of predictive SNPs in the gene (Damle et al., 1999, Ghia et al., 2003, Ghia et
al., 2007 and Kr¨ober et al., 2002). However, the original paper that published these CLL
data has also reported few significant genes (Wang et al., 2011), but none of them were
appeared as predictive SNPs in this study. Recently, two large-scale GWAS studies were
done, which identified significant SNPs associated with the CLL (Berndt et al., 2013 and
Speedy et al., 2013), and even those genes were insignificant in this analysis. This study
has incorporated a supervised machine learning approach, which was not used in
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previous studies. Also, above mentioned studies were not aimed to predict CLL, hence
the significant SNPs identified here may possibly remained hidden in their investigation.

3.9 AUC with Set of Predictive SNPs
In the end, the AUC values for the 48 predictive SNPs (with the exome kit) were
calculated individually, for few chromosomes. Chromosome 2, 6, 14, 15, 16 had more
than two predictive SNPs (Table 3.2) and so the AUC values were calculated for only
those chromosome. The AUC values are reported in Table 3.4. As it can be seen from
Table 3.4, individually, most of the predictive SNPs have significantly low AUC values
as compare to their combined AUC value. But interestingly, when predictive SNPs from
chromosome 14 were excluded from the analysis, the AUC value for the rest of the SNPs
was almost same as the AUC of top70 SNPs (The highest AUC value). Which suggests
that the SNPs from the chromosome 14 have very minor contribution in the data
classification.

Table 3.5 Average AUC Values of Predictive SNP for Different Chromosome (With the
Exome kit)
Chromosome

AUC

2
6
14
15
16
All except 14

0.77
0.64
0.79
0.67
0.80
0.93
0.94

AUC top70 SNPs

Standard Deviation
0.10
0.12
0.09
0.10
0.08
0.04
0.04
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CHAPTER 4
CONCLUSION

This investigation shows that jointly, the WES data and the supervised learning method
can effectively be utilized to implement a decent CLL risk prediction strategy.
Initially, a novel method to investigate samples containing missing information
was introduced. The effective application of the method identified 22 million structural
variants across all chromosomes. It was significantly higher compare to the 6000
variants, when the sample removal procedure is not performed. Discovering those
samples is an essential step, as single bad samples may contribute to significant amount
of data loss in downstream analysis, possibly leaving the data worthless.
Thereafter, the performance of SAMtools and of GATK was compared and it was
shown that the variants obtained with both the tools achieve almost similar prediction
accuracies. Only GATK was used in the remaining study, considering a minor better
performance and its ability to efficiently represent the missing information.
Subsequently, the effectiveness of feature selection through the PCC and the chisquare test was compared, and it was identified that the variants ranked with the PCC
obtained a classification accuracy of 66.4 % as compared to 65.1% obtained with
the chi-square. Similarly, the classification accuracy for two distinct encoding methods
was compared. Where the method Q (encoding with 7X+Y) outperforms the method P
(encoding with 0,1 and 2), it was found that with full dataset, the method Q yielded about
4% higher accuracy than the method P. With the SNPs alone, the method Q achieved
about 2% higher accuracy than the method P. It was also shown that the
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method P tends to exclude few variants while encoding genotypes whereas the method Q
efficiently encodes all the variants.
Eventually, an exome kit was taken into consideration and it led to about a 15%
rise in the classification accuracy. For the exome kit analysis, the parameters that
performed well in the prior steps were applied, which gave an average classification
accuracy of 85.7% and an AUC of 0.94. That was a significant increase from an average
classification accuracy of 70% and an AUC of 0.75 obtained without the exome kit. A
PCA analysis of top-30 SNPs (without the exome kit) and top-80 SNPs (with the exome
kit) did not show a clear separation when plotted in two dimensions, this suggests that the
CLL data are hard to classify.
During the final phase of the investigation, the predictive SNPs were identified
from an intersection of 100 training splits. The 48 predictive SNPs, obtained with the
exome kit achieved an AUC of 0.93, and the nine predictive SNPs, retrieved without the
exome kit attained an AUC of 0.75. Although the predictive SNPs achieved higher AUC
values in this study, the SNPs or the associated genes were not found to be reported in
any of the previous CLL related studies.
Overall, this study demonstrated the effective implementation of the supervised
machine-learning scheme for the CLL risk prediction. The outcome of the experiments
created the foundation for the NGS-based CLL prognostics. Since the method is fully
reproducible, it can also be applied to other diseases. However, a lack of previous
occurrences of predictive SNPs (and associated genes) in the CLL suggest that there is a
strong need of a replication study with an independent dataset to fully validate these
findings.
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